Share

April 14, 2020; 94 (15 Supplement) Tuesday, April 28

Hidden in plain sight: a rationale for repurposing apomorphine in addiction disorders (1529)

Manon Auffret, Marc Verin, Andrew Lees
First published April 14, 2020,
Citation
Permissions

Make Comment

See Comments

Downloads
0

Share

Article Information

vol. 94 no. 15 Supplement 1529
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published April 14, 2020.
Copyright & Usage: 
© 2020

Author Disclosures

    1. Manon Auffret1,
    2. Marc Verin1,2 and
    3. Andrew Lees3
  1. Manon Auffret1,
  2. Marc Verin1,2 and
  3. Andrew Lees3
  1. 1EA 4712, University of Rennes 1
  2. 2Neurology, CHU Hopital Pontchaillou
  3. 3Reta Lila Weston Institute of Neurological Studies, IoN, UCL

Article usage

Article usage: April 2020 to April 2022

AbstractFullPdfSource
Apr 20201300Highwire
May 20201600Highwire
Jun 2020200Highwire
Jul 2020500Highwire
Aug 2020200Highwire
Sep 2020100Highwire
Oct 2020400Highwire
Nov 2020100Highwire
Dec 2020900Highwire
Feb 2021600Highwire
Mar 2021200Highwire
Apr 20211400Highwire
May 2021800Highwire
Jun 2021500Highwire
Jul 2021900Highwire
Aug 2021400Highwire
Sep 2021500Highwire
Oct 2021400Highwire
Nov 2021600Highwire
Dec 2021800Highwire
Jan 2022600Highwire
Feb 20221000Highwire
Mar 20221000Highwire
Apr 2022900Highwire

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me